Literature DB >> 27862953

Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.

Shan Fang1,2, Jing Lin3, Chunxiao Li1, Peng Huang3, Wenxiu Hou4, Chunlei Zhang4, Jingjing Liu1, Sisi Huang1, Yongxiang Luo3, Wenpei Fan3, Daxiang Cui4, Yunsheng Xu1, Zhiming Li1.   

Abstract

Multimodal imaging guided synergistic therapy promises more accurate diagnosis than any single imaging modality, and higher therapeutic efficiency than any single one or their simple "mechanical" combination. Herein, we report a dual-stimuli responsive nanotheranostic based on a hierarchical nanoplatform, composed of mesoporous silica-coated gold nanorods (GNR@SiO2), Indocyanine Green (ICG), and 5-fluorouracil (5-FU), for in vivo multimodal imaging guided synergistic therapy. The 5-FU loaded ICG-conjugated silica-coated gold nanorods (GNR@SiO2-5-FU-ICG) was able to response specifically to the two stimuli of pH change and near-infrared (NIR) light irradiation. Both the NIR light irradiation and acidic environment accelerated the 5-FU release. Meanwhile, the heat generation and singlet oxygen production can be induced by GNR@SiO2-5-FU-ICG upon light irradiation. Most intriguingly, the nanoplatform also promises multimodal imaging such as two-photon luminescence, fluorescence, photoacoustic, photothermal imaging, as well as trimodal synergistic therapy such as photothermal therapy (PTT), photodynamic therapy (PDT), and chemotherapy. The cancer theranostic capability of GNR@SiO2-5-FU-ICG was evaluated both in vitro and in vivo. The trimodal synergistic therapy with the guidance of multimodal imaging exhibited remarkably enhanced treatment efficacy. This concept of a hierarchical nanoplatform integrates multiple diagnostic/therapeutic modalities into one platform, which can potentially be applied as personalized nanomedicine with drug delivery, diagnosis, and treatment.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  light-controlled drug release; multimodal imaging; pH-responsive drug release; silica-coated gold nanorods; theranostics; trimodal synergistic therapy

Mesh:

Substances:

Year:  2016        PMID: 27862953     DOI: 10.1002/smll.201602580

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  18 in total

1.  Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy.

Authors:  Dyego Miranda; Kevin Carter; Dandan Luo; Shuai Shao; Jumin Geng; Changning Li; Upendra Chitgupi; Steven G Turowski; Nasi Li; G Ekin Atilla-Gokcumen; Joseph A Spernyak; Jonathan F Lovell
Journal:  Adv Healthc Mater       Date:  2017-05-15       Impact factor: 9.933

2.  Advanced smart-photosensitizers for more effective cancer treatment.

Authors:  Wooram Park; Soojeong Cho; Jieun Han; Heejun Shin; Kun Na; Byeongdu Lee; Dong-Hyun Kim
Journal:  Biomater Sci       Date:  2017-12-19       Impact factor: 6.843

3.  Vehicle-Free Nanotheranostic Self-Assembled from Clinically Approved Dyes for Cancer Fluorescence Imaging and Photothermal/Photodynamic Combinational Therapy.

Authors:  Mingbin Huang; Chao Xu; Sen Yang; Ziqian Zhang; Zuwu Wei; Ming Wu; Fangqin Xue
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

4.  Emerging Nanotheranostics for 5-Fluorouracil in Cancer Therapy: A Systematic Review on Efficacy, Safety, and Diagnostic Capability.

Authors:  Chee Wun How; Siew Li Teoh; Jian Sheng Loh; Stella Li Kar Tan; Jhi Biau Foo; Hui Suan Ng; Stephenie Yoke Wei Wong; Yong Sze Ong
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

Review 5.  Gold nanoparticles to enhance ophthalmic imaging.

Authors:  Fang Chen; Peng Si; Adam de la Zerda; Jesse V Jokerst; David Myung
Journal:  Biomater Sci       Date:  2020-10-15       Impact factor: 6.843

Review 6.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

Review 7.  Poly(Ethylene Glycol)-Polylactide Micelles for Cancer Therapy.

Authors:  Jixue Wang; Shengxian Li; Yuping Han; Jingjing Guan; Shirley Chung; Chunxi Wang; Di Li
Journal:  Front Pharmacol       Date:  2018-03-08       Impact factor: 5.810

8.  Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics.

Authors:  Maria V Efremova; Victor A Naumenko; Marina Spasova; Anastasiia S Garanina; Maxim A Abakumov; Anastasia D Blokhina; Pavel A Melnikov; Alexandra O Prelovskaya; Markus Heidelmann; Zi-An Li; Zheng Ma; Igor V Shchetinin; Yuri I Golovin; Igor I Kireev; Alexander G Savchenko; Vladimir P Chekhonin; Natalia L Klyachko; Michael Farle; Alexander G Majouga; Ulf Wiedwald
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

Review 9.  Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications.

Authors:  Saji Uthaman; Kang Moo Huh; In-Kyu Park
Journal:  Biomater Res       Date:  2018-08-23

10.  Loading IR820 Using Multifunctional Dendrimers with Enhanced Stability and Specificity.

Authors:  Hui Liu; Jingjing Wang
Journal:  Pharmaceutics       Date:  2018-06-28       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.